AbbVie Inc (ABBV)
160.75
+0.35
(+0.22%)
USD |
NYSE |
May 10, 16:00
160.75
0.00 (0.00%)
After-Hours: 20:00
AbbVie Cash from Operations (Annual): 22.84B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.84B |
| December 31, 2022 | 24.94B |
| December 31, 2021 | 22.78B |
| December 31, 2020 | 17.59B |
| December 31, 2019 | 13.32B |
| December 31, 2018 | 13.43B |
| December 31, 2017 | 9.96B |
| December 31, 2016 | 7.041B |
| Date | Value |
|---|---|
| December 31, 2015 | 7.535B |
| December 31, 2014 | 3.549B |
| December 31, 2013 | 6.267B |
| December 31, 2012 | 6.345B |
| December 31, 2011 | 6.247B |
| December 31, 2010 | 4.976B |
| December 31, 2009 | 5.367B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
13.32B
Minimum
2019
24.94B
Maximum
2022
20.29B
Average
22.78B
Median
2021
Cash from Operations (Annual) Benchmarks
| Amgen Inc | 8.471B |
| Johnson & Johnson | 22.79B |
| Eli Lilly and Co | 4.240B |
| Merck & Co Inc | 13.01B |
| Pfizer Inc | 8.70B |